To evaluate the central nervous system toxicity of cisplatin and neuroprotective effect of selenium.
Introduction
Cisplatin (cis-diamminedichloroplatinum II; Cis), a platinum based alkylating potent anticancer drug, is widely used in many types of cancers such as testicular, ovarian, colorectal, lung, breast, head and neck cancers [1] [2] [3] [4] . However, use of cisplatin in tumor therapy has some harmful effects which can be detected virtually on all tissues. Some side effects of cisplatin exposure are auditory toxicity, nephro-toxicity, cardio-toxicity, gonado-toxicity, hepato-toxicity, ototoxicity, central and peripheral neurotoxicity 5, 6 .
Neurotoxicity induced by cisplatin is one of the most important dose limiting toxicities. Studies have revealed that up to 30%
of patients given cisplatin have neurotoxicities 7 . Furthermore, numerous studies have shown that cisplatin increases the rate of apoptotic cell death.
Selenium is an essential trace element and taken in very low levels by diet. It shows antioxidant and neuroprotective effects by scavenging free oxygen radicals. Selenium is a cofactor for glutathione peroxides (GPx) and protects DNA, lipids and protein by reducing hydro peroxides and lipoperoxidases 8, 9 . Selenium is also an important component of several selenoproteins which are expressed in brain. Many previous studies reported that selenium has a neuroprotective effect [10] [11] [12] .
Currently many chemo protective agents such as erythropoietin, fish oil, valproate, vitamin E, melatonin and alpha lipoic acid were used to reduce or prevent the neurotoxic effect of the cisplatin in various in vivo and in vitro studies through different cellular targets [13] [14] [15] [16] [17] [18] . However, to our knowledge, there is not any previous study which investigated whether selenium can reduce or prevent cisplatin induced central neurotoxicity.
In the present study, we aimed to evaluate whether selenium can reduce cisplatin induced neurotoxicity in an animal model. Within this context, the putative histopathological and immunohistochemical changes were evaluated in brain of the rats.
Methods
Study protocols and experimental methods were use. In total of 21 adult male Wistar-Albino rats, weighing 280-300 g were randomly divided into three groups of seven rats each:
Group C (Control, n=7), Group CS (Cisplatin, n=7), Group CSE (Cisplatin+ Selenium, n=7).
Cisplatin (Sigma-Aldrich Co, Germany) was administered to the rats in CS and CSE groups at a dose of 12 mg/kg body weight/day, intraperitoneally for 3 consecutive days 19, 20 . In addition to cisplatin, rats in CSE group were given 3 mg/kg body weight/ day selenium (Sodium selenite, Sigma-Aldrich Co., Germany) by oral gavage twice-a-day as 1.5mg/kg 21 
Histopathological and immunohistochemical analysis
The cerebrum tissues fixed by 10% buffered formalin were dehydrated and embedded in paraffin and serial sections were cut using a microtome. The sections were stained with
Crossman modified Mallory's triple staining for histopathological evaluations. In addition, photomicrographs were taken. Evaluations of the cerebrum for histopathologic changes and cerebral cortex structure were done under high-power light microscopic (Nikon Eclipse i50).
For immunohistochemical analysis, the cerebrum tissues were stained with bax which initiates apoptosis and with bcl-2 which protects against apoptosis (Bax and bcl-2, Santa Cruz Biotechnology). For inhibition of endogenous peroxides activity, samples were treated with 0.3% H 2 O 2 , and then incubated in 1% normal bovine serum to reduce non-specific binding sites. Bax and bcl-2 primary antibodies were incubated at +4°C temperature for 18 hours. These sections were incubated with biotinylated secondary antibody and streptavidin-HRP for 1 hour, and then 3,3'-diaminobenzidine tetrahydrochloride (DAB) substrate kits for 3-5 min to obtain immunolabelling. Finally, nuclei were counterstained with Mayer's haematoxylin.
Image analysis was performed using a personal computer, a camera, software (Kameram SLR, 1.6.1.0, Mikro Sistem, Ltd.
Sti. Turkey) and an optical microscope. The number of bax and bcl-2 immunohistochemical positive cells in five randomly chosen microscopic fields was counted. These cell numbers were used to measure the balance between cell survival and cell death, and the bax/bcl-2 ratio was calculated by dividing the % of bax (+) cells by the % of bcl-2 (+) 23 .
In addition, the intensity of staining with antibodies was subjectively scored 24 
Statistical analysis
All values were expressed as mean ± standard deviation. The numbers of bax and bcl-2 immunopositive cells were analyzed using a one-way analysis of variance (ANOVA). Significant differences among treatment means were determined by using Duncan's. Differences with a p<0.05 were considered significant.
Results

Histopathological evaluation
In the C group; the layer of the cerebral cortex had normal histological appearances. Margins of neurons of the cerebrum were distinct and cell membrane integrity was preserved. Furthermore, nucleolus was distinctively observed and nucleolus margins were regular. In the CS group; most of the big pyramidal shaped neurons had heterochromatic nucleus and vacuolated area was shaped around the neurons. Dilatations of the capillary vessels were observed in the all layer of the cerebrum in the CS group. The structures of the squamous epithelium of the vascular endothelial cells were rounded and increased lumen diameter with oval-round shape was observed.
Moreover, a few peripherally located neuroglia cells were detected around the neurons ( Figure 1A ). In the CSE group; markedly decreased the number of the heterochromatic cells and polarized neuroglia cell and decreased capillary lumen width were observed. Besides this the structures of the most capillary vessels lumen were similar to the structure of the control group capillary vessels ( Figure 1B) . 
Immunohistochemical evaluation
In the present study, for determination of apoptotic and antiapoptotic activities of the neurons, streptavidin-biotin peroxidase staining was used to detect bax and bcl-2 protein. The results of immunohistochemical staining were shown in Table 1 .
Cytoplasmic staining of the cell for bcl-2, both cytoplasmic and nuclear staining for bax, were determined to be positive in the all groups. In the C group, bax (+) reactions were rarely observed in the small pyramidal shaped neurons (Figure 2A ), but bcl-2 positive cells were higher in all cortical neurons and rarely glial cells ( Figure   2B ). In the CS group, bax (+) reactions were observed higher in the cytoplasma and nucleus of the small and large pyramidal shaped neurons and were slightly reactions observed in the protoplasmic astrocytes and oligodendrocytes forming neuroglia tissue ( Figure   3A ). In addition, an increase was determined in bax/bcl-2 ratio in the CS group (2.72) when compared to the control (0.38) group.
Both factors (decrease in antiapoptotic bcl-2 activity and increase in apoptotic bax activity) led this situation ( Figure 3B 
Discussion
Cisplatin is a very effective drug which is commonly used in the treatment of solid tumors such as colorectal, head and neck, ovarian, testicular, lung, breast, and bladder tumors.
Due to the widespread side effects of cisplatin, its use is limited.
Comprehensive neurologic and neurophysiologic examinations
have revealed that all patients receiving cisplatin treatment with cumulative doses higher than 300mg/m 2 develop signs of neurotoxicity 15 . Cisplatin neurotoxicity including ototoxicity, peripheral sensory polyneuropathy and focal encephalopathy are among the most important dose limiting toxicities 15, 16 . Many previous studies have focused on the neurotoxicity of cisplatin in peripheral neuropathy and effectiveness of chemo protective agents 6, 18, 25, 26 . Only a few studies have focused on central neurotoxicity of cisplatin 13, 27, 28 .
Dietrich et al. 28 showed that anti-cancer drugs (Carmustine, cisplatin and cytosine arabinoside) are severely toxic for the progenitor cells of the central nervous system and for non-dividing oligodentrocytes than for cancer cells. In addition, they reported that systemically administration of cisplatin increased the cell death and decreased cell division in the dentate gyrus of the hippocampus and in the corpus callosum. Another study conducted by Rzeski et al. 27 reported that cisplatin was the second most neurotoxic anti-cancer drug after vinblastin with 30% neuronal death at 100 µM and 100% neuronal death at 500 . In addition, many previous studies have reported that both short and long term administration of cisplatin causes significant oxidative damage, formation of reactive oxygen species or free radicals in many tissues such as brain, testis, liver, and kidney 24, 30 .
Furthermore, experimental animal studies, focused on the role of antioxidants such as vitamin E, vitamin C, erythropoietin, thalidomide, melatonin, alpha lipoic acid, and fish oil, found out that these antioxidant agents are effective in cisplatin toxicities 15, 31 .
Another possible mechanism of cisplatin-induced neurotoxicity is apoptosis and/or mitochondrial dysfunction. Apoptosis, called as programmed cell death consists of biochemical and histopathological changes leading to morphologic degenerations These results demonstrate that the bax activity increase might be correlated with cisplatin induced apoptosis.
Selenium acts as the part of the active site of GPx.
GPx is a seleno-enzyme that reduces the mitochondrial stress, . In this study, selenium treatment before and after cisplatin injection reduced apoptotic neuron and glial cell counts but increased antiapoptotic Bcl-2 activity. These findings suggest that the overexpression pattern of the Bcl-2 protein caused by selenium may be necessary in chemotherapy.
Conclusion
Selenium may histopathologically and immunohistopathologically prevent cisplatin-induced central neurotoxicity.
